The 4th General Assembly of the ELMUMY project took place in Athens, Greece on October 4, 2024. This event brought together all consortium partners to discuss the progress and future direction of our EU-funded initiative aimed at understanding and revolutionizing the treatment of Multiple Myeloma.
Held in a coastal suburb of Athens, the Assembly served as a platform for robust discussions, strategic planning, and knowledge sharing as we continue to advance our research in combating this complex form of blood cancer.
The meeting centered on the progress of the project, examining updates on ongoing work packages and addressing the challenges faced by partners over the past eight months. A crucial segment of the discussion was devoted to planning the implementation of future steps.
The ELMUMY consortium is dedicated to accelerating the development of innovative solutions for multiple myeloma treatment, and the success of this General Assembly reinforces our shared determination to achieve this goal.
Comments